First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (NCT05489237)

🧪 Interventions in This Study

• IDRX-42 (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (31 Sites)

Showing the first 25 of 31 sites.

• GSK Investigational Site — Miami, Florida
• GSK Investigational Site — Chicago, Illinois
• GSK Investigational Site — Boston, Massachusetts
• GSK Investigational Site — St Louis, Missouri
• GSK Investigational Site — New York, New York
• GSK Investigational Site — Portland, Oregon
• GSK Investigational Site — Philadelphia, Pennsylvania
• GSK Investigational Site — Houston, Texas
• GSK Investigational Site — Leuven,
• GSK Investigational Site — Beijing,
• GSK Investigational Site — Guangzhou,
• GSK Investigational Site — Wuhan,
• GSK Investigational Site — Bordeaux,
• GSK Investigational Site — Lyon,
• GSK Investigational Site — Marseille,
• GSK Investigational Site — Villejuif,
• GSK Investigational Site — Berlin,
• GSK Investigational Site — Essen,
• GSK Investigational Site — Milan,
• GSK Investigational Site — Chiba,
• GSK Investigational Site — Kanagawa,
• GSK Investigational Site — Tokyo,
• GSK Investigational Site — Amsterdam,
• GSK Investigational Site — Rotterdam,
• GSK Investigational Site — Seongnam-si Gyeonggi-do,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Gastrointestinal Neoplasms

• Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei — Houston, Texas
• Monopolar Current Cutting Knife vs Bipolar RFA Knife — Houston, Texas
• Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer — Duarte, California
• Feasibility and Prospective Study of a Dynamic Traction Device for Use During ESD — Houston, Texas
• The Canopy Cancer Collective Clinical Registry Protocol — San Diego, California

Explore by condition: All Gastrointestinal Neoplasms clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.